I keep expansion honest by making the number, the capacity, and the kill criteria visible in the same room before anyone falls in love with a deal. A CEO and board stay aligned on deal-led growth when they share one definition of winning in year one, one view of what the base can absorb, and one agreement about what “support” means when the calendar gets tight. Without that, expansion becomes a vibe—and vibes do not survive a miss.
This is not a lecture about governance theory. It is how I behave in board packs, IC memos, and the quiet sidebar after a banker leaves the room. Sponsors feel time. Operators feel plants and customers. Both are real. Alignment is the work of translating those realities into a shared decision, not a shared slogan.
I have run two companies above a billion dollars—one at $1.1 billion and one at $1.5 billion—and I have helped create more than $3 billion in shareholder value. That experience did not make politics disappear. It made me allergic to ambiguous nods that later get rewritten as mandates.
How should a CEO and board stay aligned when the company is expanding through deals?
Stay aligned on three objects, refreshed often: the board number, the absorb-capacity status of the base, and the deal queue with kill criteria. If those three are current, debate can be sharp without becoming personal. If they are stale, every deal conversation becomes a referendum on trust.
Alignment is not agreement on every asset. Alignment is agreement on how we decide, what we will not trade away, and how we will talk when we disagree. Expansion without that agreement turns the CEO into a translator after the fact—an exhausting job that usually ends in a miss and a story about “communication.”
I also align on language. “Accretive,” “strategic,” “must-win,” and “transformational” are not synonyms. If the board uses them interchangeably, the operating team will hear permission to stretch. Stretch without capacity is how platforms break while the minutes still say “unanimous support.”
What is “the number,” and why do I treat it as a moral object?
The number is the board-owned expression of value creation for the period—usually an EBITDA (or equivalent) outcome with a bridge people can explain. It is moral because people organize their weeks around it. If the number is fake, the organization learns to perform. If the number is real, the organization learns to decide.
When deals enter the chat, the number gets political. Someone wants the deal’s upside in the same breath as base commitment. Someone else wants optionality without changing the forecast. I force the split into the open: what is the base number without the deal, what is the deal contribution by date, and what happens to the board pack if synergy slips?
A bridge the room can own is worth more than a model the room can admire. The Institute’s 5-lever EBITDA bridge work is the practical language I like for that conversation. Soft pointer, hard habit: if we cannot bridge it, we should not brand it as commitment.
How do I keep sponsors from treating the base as deal collateral?
Directly, early, and with a calendar. I show what the base already owes. I show which leaders are already spoken for. I show which prior-deal commitments are still yellow. Then I ask what we are willing to put at risk for pace.
Sponsors who want speed deserve a clear menu: speed with accepted base risk, or capacity with deferred opportunity. What they should not get is a smile that implies both with no tradeoff. I have given that smile earlier in my career. It feels like leadership in the meeting and like loneliness after the miss.
When a sponsor says “we’ll support you,” I ask what support means on a Tuesday when a plant and a synergy workshop collide. Support that cannot name a decision right is encouragement, not governance.
What belongs in a board pack when multi-expansion is live?
I want the pack to make a non-executive able to ask a real question in five minutes. That means:
- Base bridge versus the number, with actions—not adjectives.
- Deal queue: thesis fit, stage, capacity claim, kill criteria.
- Integration load: owners, Day-100 status, base-impact alerts.
- Customer continuity for material deals: top-account health.
- Cash and covenant view if leverage is part of the story.
I avoid drowning the board in CIM excerpts. Boards do not need a tour. They need a decision architecture. If a director has to reverse-engineer our capacity from footnotes, we failed the pack.
For a board-ready strategy rhythm that survives more than a deal cycle, the Publishing piece on a board-ready strategy management process and the book The Strategy Management Process are where I send teams who want the system written down. Expansion honesty is easier when strategy cadence already exists.
How do I run disagreement in the room without theater?
I name the disagreement as a tradeoff, not a character test. “We disagree on pace versus base risk” is workable. “You are not ambitious” is not. Ambition accusations are how adults stop telling the truth.
I bring options with consequences. Option A: pursue the deal now, accept these capacity moves, accept these base risks, accept this kill date if X is true. Option B: defer, finish yellow commitments, revisit when absorb capacity recovers. Option C: pass for thesis reasons, log the learning.
Then I ask the board to choose—not to “support management” in the abstract. Abstract support is a future argument waiting for a bad quarter.
Minutes should capture the choice and the accepted risk. If the minutes only say “discussed and approved,” we have created a document that helps no one when memory gets selective.
What kill criteria make expansion feel adult instead of romantic?
Kill criteria are pre-agreed facts that end the chase: price above X without a new proof of thesis, a customer concentration discovery beyond Y, an IT reality that blocks weekly truth, a key-person exit that the thesis cannot survive, or a base miss that consumes the capacity we planned to spend.
Romantic expansion treats kill criteria as negativity. Adult expansion treats them as freedom. You can pursue hard when stopping is defined.
I put kill criteria in writing before management charm peaks. Charm is real. Sellers are often impressive. That is why criteria exist—so admiration does not silently rewrite the investment case.
How should IC and board conversations differ without conflicting?
IC is where capital allocation gets sharp. The board is where operating accountability stays continuous. They should not tell different stories. They should emphasize different depths.
In IC, I expect harder math and clearer walk-aways. In board, I expect clearer operating implications and capacity truth. If IC hears a glowing synergy story and the board hears a calm “no impact to the base,” someone is managing narratives instead of governing.
I try to keep one source of truth for capacity and one source of truth for the number. Multiple decks with multiple bridges are how alignment dies politely.
What does Day 100 reporting owe the board after a deal?
Not a victory lap. A status against the promises that justified the capital: thesis proof started, must-not-break list held, base number still owned, integration load still staffed. If those are green, celebrate briefly and move on. If they are yellow, reset owners and dates in the open.
I avoid burying yellow status in an appendix. Boards can handle yellow. They cannot handle surprise red that was yellow for two months in private.
Day 100 is also when we decide whether the next deal is even discussable. That decision belongs in the same meeting as the status, not in a sidebar after everyone has left.
How do I keep culture and incentives from fighting the board number?
If leaders are paid for deal volume while the board number depends on base health, the organization will follow the money. I push for incentives that reward the bridge outcomes we claim to want—price, mix, cost discipline, customer continuity—not logo count.
I also watch informal incentives: who gets airtime, who gets promoted, who gets forgiven for a miss if they were “strategic.” Informal incentives train faster than plan documents.
When expansion is live, I ask HR and finance a blunt question: what behavior are we currently rewarding that would hurt the base if everyone maximized it? Then we fix that before we congratulate ourselves on alignment.
What do I do when trust is already thin?
Slow the narrative, speed the truth. Thin trust plus a hot deal process is how people get hurt. I shrink the decision set. I increase the frequency of short, factual updates. I stop selling optimism as a substitute for data.
Sometimes the right move is a deliberate pause on new LOIs until the base bridge is believed again. That can feel like weakness to a sponsor under clock pressure. It is often the only way to restore the credibility required for the next yes.
Hopeful does not mean performative. Hopeful means we can still get to a clean hold if we stop lying to ourselves about capacity.
How do I talk about expansion with PE audiences without turning it into a war story?
I talk about decision systems: thesis, capacity, sequencing, kill criteria, board number. War stories entertain. Decision systems transfer. When I speak to PE audiences, I would rather leave them with a sharper filter than with a memorable anecdote about a plant tour.
If that is useful for your partners’ offsite or operating summit, see speaking. If you want the working relationship rather than the keynote, start with advisory. And if you want the longer public conversation, 1000 Day CEO is where these topics stay in operator language.
What does honest expansion look like twelve months later?
Twelve months later, honest expansion looks like a base that still makes its number (or has an explained, owned recovery), a deal thesis with at least one visible proof, and a leadership team that is not secretly relieved when the next process slips. It looks like directors who remember the tradeoffs they accepted because those tradeoffs were written down. It looks like a sponsor relationship that can survive a pass without drama.
It does not look perfect. Integration is still messy. Systems are still ugly. People still disagree. The difference is that disagreement happens against a shared number and a shared capacity truth—not against competing memories of what “we all agreed.”
How do I pre-wire a deal conversation without turning it into a campaign?
Pre-wiring is adult. Campaigning is politics. The difference is intent and content. I pre-wire facts: capacity, kill criteria, base bridge, and the decision options. I do not pre-wire applause.
A useful pre-wire is ten minutes with the board chair and the lead director: here is what we know, here is what would change my mind, here is what I need from the room. If they cannot support the frame, better to learn that before the full meeting becomes a stage.
I avoid one-off private forecasts that differ from the pack. Private forecasts create a second number. Second numbers destroy alignment faster than a hard disagreement about pace.
What questions should directors ask when management is excited?
Directors should ask what we will stop. Excitement without subtraction is a capacity warning. They should ask which base commitments become harder if this deal closes in the proposed window. They should ask what yellow items from prior deals are still open. They should ask how the number changes if synergy is cut in half.
They should also ask who personally owns customer continuity for the top accounts. If the answer is “the integration team,” press for names. Teams do not call customers at 6 a.m. when a shipment slips. People do.
Good directors are not anti-deal. They are anti-ambiguity. Ambiguity is where CEOs get lonely and sponsors get surprised.
How do I keep the first hundred days from becoming a board narrative problem?
I set Day-100 expectations in the approval meeting, not after close. What proof of thesis will exist? What will still be intentionally unfinished? What base metrics must stay inside a range? What will trigger an emergency update?
Then I report against those expectations without rebranding. If we said we would stabilize billing and land one cross-sell proof, I do not replace that with a story about “cultural alignment workshops completed.” Workshops can matter. They are not the number.
When we miss a Day-100 mark, I bring a recovery plan with dates and owners in the same meeting. Missing happens. Unowned missing becomes a trust event. Trust events make the next deal harder even when the thesis is right.
What does “support” look like when the base number is under pressure?
Support looks like helping the CEO protect capacity—even if that means slowing a process the sponsor likes. Support looks like refusing to add five new “simple” asks during a wobble. Support looks like backing a public pass when walk-away criteria are hit, without rewriting history as “management lost conviction.”
Support does not look like silence in the meeting and frustration in the hallway. Hallway governance is how boards create CEOs who stop bringing bad news early.
When pressure is high, I ask the room to reaffirm the hierarchy: base number first, thesis proof second, pace third. If the room wants a different hierarchy, we say so and accept the consequences. Unspoken hierarchy changes are how expansion becomes dishonest.
How do I close the loop after a pass so the board still trusts the next yes?
After a pass, I bring a short postmortem to the next board meeting: why we looked, why we stopped, what we learned about our thesis or capacity, and what would make a similar asset interesting later. This turns a pass into governance, not awkward silence.
I also update the deal queue visibly. Empty silence after a public process makes directors invent stories. Invented stories are rarely generous. A clean log prevents mythology.
When the next yes arrives, I can point back to the pass as proof that filters work. Boards trust conviction more when they have watched you walk. Walking once buys credibility for pursuing hard later—especially when the number is still intact.
If the pass was messy—late information, heated process, bruised egos—I still close the loop. Messy passes need more sunlight, not less. Sunlight is how the next IC memo stays believed.
FAQ: boards, sponsors, and expansion
Who owns the board number when a deal is in flight?
The CEO owns the operating commitment. The board owns the definition and the acceptance of risk. Sponsors own capital allocation consequences. Confusion among those three is how misses become blame exercises.
Should every deal go to the full board?
Material deals and anything that taxes capacity enough to threaten the number should. Small, on-thesis bolt-ons can follow a delegated framework—if the framework includes kill criteria and a capacity check, not just a size threshold.
How often should absorb capacity be reviewed?
At least as often as you refresh the deal queue. In a hot market, that can mean monthly. Capacity that is only discussed when a CIM arrives is capacity that will always say yes too late.
What is the fastest way to destroy board alignment?
Different stories in IC and board. Hidden yellow status. Ambiguous “support.” Moving kill criteria after charm. Any one of those will do. Two of them together will do it quickly.
Where should a CEO start if the board pack is already noisy?
Cut to the number, the capacity, and the queue. Link out to deeper systems if helpful—the EBITDA bridge, a board-ready strategy process—but start the meeting where decisions live.
If you want the room to stay honest while you expand
Boards, sponsors, and CEOs do not stay aligned by accident during multi-expansion. They stay aligned by making tradeoffs visible and by refusing to let deal heat rewrite the number. If you want help installing that discipline, start with advisory. If you want it as a talk for partners and operators, look at speaking. If you want the written strategy cadence behind the board pack, read the board-ready strategy management essay and The Strategy Management Process. For bridge language the room can share, use the Institute’s 5-lever EBITDA bridge. And for the ongoing operator conversation, listen at 1000dayceo.com.
Keep the number honest. Keep capacity visible. Keep kill criteria adult. That is how expansion compounds instead of performing.
